ABSTRACT
Introduction Exposure to second-hand tobacco smoke generates a considerable health burden globally. In south-east Asia, most of that burden falls on women and children who are exposed to second-hand smoke from male smoking in their home. Interventions to encourage smoke-free homes have tended to target smokers individually or within their family unit, although some evidence suggests a community-wide approach holds promise. This study co-developed an intervention toolkit that could be applied to small village/town communities in Indonesia and Malaysia.
Methods The CO-FRESH study used four work packages to: (i) create online training materials to equip local health professionals to tackle smoking in the home; (ii) create a local public information campaign on the benefits of a smoke-free home; (iii) establish methods to provide household air quality feedback to highlight the impact of smoking in the home; and (iv) map local existing services to support families to create smoke-free homes.
Results Four specific communities (two in each country) were involved in intervention development. Training materials for health professionals and a toolkit for use by communities to encourage smoke-free homes were co-created. Communities welcomed the concept of tackling smoking in the home, however there was a lack of knowledge about how second-hand smoke moved around the home and could enter indoor spaces from outdoor smoking. The concept of a ‘smoke-free’ home was often misunderstood, alongside what constitutes indoor versus outdoor space. In addition, findings of high background air pollution levels mean that household air quality measurement may not be suited to providing second-hand smoke information in these communities.
Conclusions Communities in Malaysia and Indonesia recognised the importance of reducing smoking in the home, and welcomed the approach of co-developing community-wide methods of tackling the issue. The CO-FRESH toolkit requires evaluation to determine effectiveness and how it can be implemented at scale.
What is already known on this topic?
Exposure to second-hand smoke causes nearly 300,000 child deaths per year globally.
As a result of high prevalences of adult male smoking, children in South-East Asia have a particularly high rates of exposure to SHS; 58% of children are exposed to SHS in Indonesia and 49% in Malaysia.
What does this study add?
Whilst participants showed some understanding of the health harms associated with second-hand smoke, many did not realise that smoke travels from one room to another, and can linger in the air for up to five hours.
Although men often accepted smoking in the home as a social norm, and women spoke of challenges raising the issue with them, community members and health professionals welcomed the concept of creating a smoke-free home to better protect familial health.
How this study might affect research, practice or policy?
This study co-developed the CO-FRESH smoke-free homes intervention toolkit, which could be delivered in small village/town communities in Indonesia and Malaysia by healthcare professionals, community leaders and/or peers, to reduce exposure to second-hand smoke in both countries.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the Medical Research Council.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The University of Stirling General University Ethical Panel, Universitas Gadjah Mada Faculty of Medicine, Public Health and Nursing Medical and Health Research Ethics Committee, and the University Putra Malaysia Ethics Committee for Research involving Human Subjects all gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.